Recent studies, including our own, have shown that LIF is frequently overexpressed in many cancer types, and elevated serum LIF levels have been observed in patients with different cancer types, including PDACs, OACs, and nasopharyngeal carcinomas (NPCs)17–19,36. The gene discussed is LIF; the disease is nasopharyngeal carcinoma.